Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging

Tarec Christoffer El-Galaly, Francesco d'Amore, MD, DMSci, Peter de Nully Brown, Ilse Christiansen, Lena Specht, Annika Loft, Anne Bukh, Hans E. Johnsen, Charlotte Madsen, Martin Hutchings

Blood (2011) 118 (21): 2627.

https://doi.org/10.1182/blood.V118.21.2627.2627

Published: 2011

Journal Articles

Absence of Anaplastic Large Cell Lymphoma Cases in a Large Cohort of Danish Women with Breast Implants: Results of a Nationwide, Population-Based Study,

Maja Ølholm Vase, MD, Søren Friis, MD, Andrea Bautz, MSc, Henrik Toft Sørensen, MD, DMSci, Francesco d'Amore, MD, DMSci

Blood (2011) 118 (21): 3689.

https://doi.org/10.1182/blood.V118.21.3689.3689

Published: 2011

Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Blood (2011) 118 (21): 331.

https://doi.org/10.1182/blood.V118.21.331.331

Published: 2011

Journal Articles

Development of a Splenic Marginal Zone Lymphoma Associated with Active Chronic Visceral Leishmaniasis

Maja Ølholm Vase, MD, Ylva Kristina Hellberg, MD, Carsten Schade Larsen, PhD, Jørgen Eskild Petersen, PhD, Henrik Schaumburg, MD, Knud Bendix, MD, PhD, Christophe Ravel, PhD, Patrick Bastien, PhD, Mariann Christensen, Charlotte Guldborg Nyvold, M.Sci., Ph.D., Francesco d'Amore, MD, DMSci

Blood (2011) 118 (21): 5202.

https://doi.org/10.1182/blood.V118.21.5202.5202

Published: 2011

Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Blood (2011) 118 (21): 4110.

https://doi.org/10.1182/blood.V118.21.4110.4110

Published: 2011

Journal Articles

Monocytosis in the Peripheral Blood At First Relapse/Progression Predicts Poorer Overall and Progression-Free Survival After Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma

Marie Toft-Petersen, Peter Kamper, Signe Albertsen, Louise Secher, Erik Kay Segel, Michael Clausen, Francesco d'Amore, MD, DMSci

Blood (2011) 118 (21): 1559.

https://doi.org/10.1182/blood.V118.21.1559.1559

Published: 2011

Journal Articles

Expression Level, Tissue Distribution Pattern and Prognostic Impact of Vascular Endothelial Growth Factor (VEGF) and Its Receptors Flt-1 and KDR in Different Subtypes of Non-Hodgkin Lymphoma (NHL).

Judit M. Jørgensen, MD, Flemming B. Sørensen, MD, DMSci., Knud Bendix, MD, DMSci, Johan L. Nielsen, MD, DMSci., Anette Funder, Tapio Tainola, Annette B. Sørensen, PhD, Francesco d’Amore, MD, DMSci.

Blood (2005) 106 (11): 2824.

https://doi.org/10.1182/blood.V106.11.2824.2824

Published: 2005

NARROW

Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging

Absence of Anaplastic Large Cell Lymphoma Cases in a Large Cohort of Danish Women with Breast Implants: Results of a Nationwide, Population-Based Study,

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Development of a Splenic Marginal Zone Lymphoma Associated with Active Chronic Visceral Leishmaniasis

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Monocytosis in the Peripheral Blood At First Relapse/Progression Predicts Poorer Overall and Progression-Free Survival After Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma

Expression Level, Tissue Distribution Pattern and Prognostic Impact of Vascular Endothelial Growth Factor (VEGF) and Its Receptors Flt-1 and KDR in Different Subtypes of Non-Hodgkin Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging

Absence of Anaplastic Large Cell Lymphoma Cases in a Large Cohort of Danish Women with Breast Implants: Results of a Nationwide, Population-Based Study,

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Development of a Splenic Marginal Zone Lymphoma Associated with Active Chronic Visceral Leishmaniasis

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Monocytosis in the Peripheral Blood At First Relapse/Progression Predicts Poorer Overall and Progression-Free Survival After Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma

Expression Level, Tissue Distribution Pattern and Prognostic Impact of Vascular Endothelial Growth Factor (VEGF) and Its Receptors Flt-1 and KDR in Different Subtypes of Non-Hodgkin Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only